To determine whether this association applied to tumour-specific TILs, we tracked longitudinally—from tumour tissue throughout the ex vivo expansion—215 individual CD8+ TIL clonotypes that were previously determined to be tumour-reactive12 (Methods). This evidence concerns the gene CD8A and neoplasm.